National Institutes of Health Statement of Organization, Functions, and Delegations of Authority, 7216 [2011-2848]

Download as PDF 7216 Federal Register / Vol. 76, No. 27 / Wednesday, February 9, 2011 / Notices [4] The Commission has previously taken action where the credit reporting agency failed to adequately screen purchasers of consumer credit information. For instance, in United States v. ChoicePoint, Inc., 09–CV– 0198 (N.D. Ga. Oct. 19, 2009), the Commission alleged that the failure to screen customers led to the sale of 160,000 credit reports to identity thieves posing as customers of ChoicePoint. [5] The Fair Credit Reporting Act authorizes the Commission to seek civil penalties for violations of the Act. 15 U.S.C. 1681s(a)(2)(A). [FR Doc. 2011–2790 Filed 2–8–11; 8:45 am] BILLING CODE 6750–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES mstockstill on DSKH9S0YB1PROD with NOTICES National Institutes of Health Statement of Organization, Functions, and Delegations of Authority Part N, National Institutes of Health, of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services (40 FR 22859, May 27, 1975, as amended most recently at 66 FR 6617, January 22, 2001, and redesignated from Part HN as Part N at 60 FR 56605, November 9, 1995), is amended as set forth below to establish the Office of Portfolio Analysis (OPA) and Office of Program Evaluation and Performance (OPEP) within the Division of Program Coordination, Planning and Strategic Initiative (DPCPSI) within the Office of the Director. Section N–AW, Organization and Functions, is amended as follows: Immediately after the paragraph headed ‘‘Office of Portfolio Analysis and Strategic Initiatives’’ (N AW6, formerly HN AW6), insert the following: Office of Portfolio Analysis (N AW7, formerly N AW7) (1) Prepare and analyze data on NIH sponsored biomedical research to inform trans-NIH planning and coordination; (2) serve as a resource for portfolio management at the programmatic level; (3) employ databases, analytic tools, methodologies and other resources to conduct assessments in support of portfolio analyses and priority setting in scientific areas of interest across NIH; (4) research and develop new analytic tools, support systems, and specifications for new resources in coordination with other NIH organizations to enhance the management of the NIH’s scientific portfolio; and (5) provide, in coordination with other NIH organizations, training on portfolio analysis tools, procedures, and methodology. VerDate Mar<15>2010 17:08 Feb 08, 2011 Jkt 223001 Office of Program Evaluation and Performance (N AW8, formerly N AW8) (1) Plan, conduct, coordinate, and support program evaluations, including IC-specific program and project evaluations and trans-NIH evaluations; (2) manage and administer NIH’s Evaluation Set-Aside Program; (3) coordinate and direct the preparation of plans and reports required by the Government Performance and Results Act (GPRA), including the development of required performance measures; (4) identify and advise on emerging national issues within program evaluation and performance, including NIH’s response to legislative, regulatory, and policy requirements of the GPRA and administration of the NIH-wide evaluation program. Delegations of Authority Statement: All delegations and redelegations of authority to officers and employees of NIH that were in effect immediately prior to the effective date of this reorganization and are consistent with this reorganization shall continue in effect, pending further redelegation. Dated: January 21, 2011. LaVerene Stringfield, Associate Director for Management, OD, ES, NIH. [FR Doc. 2011–2848 Filed 2–8–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30 Day–11–10BG] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project National Voluntary Environmental Assessment Information System (NVEAIS)—New—National Center for Environmental Health (NCEH), Centers for Disease Control and Prevention (CDC). PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 Background and Brief Description The CDC is requesting OMB approval for a National Voluntary Environmental Assessment Information System to collect data from foodborne illness outbreak environmental assessments routinely conducted by local, state, territorial, or tribal food safety programs during outbreak investigations. Environmental assessment data are not currently collected at the national level. The data reported through this information system will provide timely data on the causes of outbreaks, including environmental factors associated with outbreaks, and are essential to environmental public health regulators’ efforts to respond more effectively to outbreaks and prevent future, similar outbreaks. The information system was developed by the Environmental Health Specialists Network (EHS–Net), a collaborative project of federal and state public health agencies. The EHS–Net has developed a standardized instrument for reporting data relevant to foodborne illness outbreak environmental assessments. State, local, tribal, and territorial food safety programs are the respondents for this data collection. Although it is not possible to determine how many programs will choose to participate, as NVEAIS is voluntary, the maximum potential number of program respondents is approximately 3,000. However, these programs will be reporting data on outbreaks, not their programs or personnel. It is not possible to determine exactly how many outbreaks will occur in the future, nor where they will occur. However, we can estimate, based on existing data that a maximum of 1,400 foodborne illness outbreaks will occur annually. Only programs in the jurisdictions in which these outbreaks occur would report to NVEAIS. Consequently, we have based our respondent burden estimate on the number of outbreaks likely to occur each year. Assuming each outbreak occurs in a different jurisdiction, there will be one respondent per outbreak. Each respondent will respond only once per outbreak investigated. There are two activities for which we need to estimate burden for these programs. The first is entering all requested environmental assessment data into NVEAIS. This will be done once for each outbreak. This will take approximately 120 minutes per outbreak. The second activity requiring a burden estimate is the manager interview that will be conducted at each establishment associated with an E:\FR\FM\09FEN1.SGM 09FEN1

Agencies

[Federal Register Volume 76, Number 27 (Wednesday, February 9, 2011)]
[Notices]
[Page 7216]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-2848]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institutes of Health Statement of Organization, 
Functions, and Delegations of Authority

    Part N, National Institutes of Health, of the Statement of 
Organization, Functions, and Delegations of Authority for the 
Department of Health and Human Services (40 FR 22859, May 27, 1975, as 
amended most recently at 66 FR 6617, January 22, 2001, and redesignated 
from Part HN as Part N at 60 FR 56605, November 9, 1995), is amended as 
set forth below to establish the Office of Portfolio Analysis (OPA) and 
Office of Program Evaluation and Performance (OPEP) within the Division 
of Program Coordination, Planning and Strategic Initiative (DPCPSI) 
within the Office of the Director.
    Section N-AW, Organization and Functions, is amended as follows: 
Immediately after the paragraph headed ``Office of Portfolio Analysis 
and Strategic Initiatives'' (N AW6, formerly HN AW6), insert the 
following:
    Office of Portfolio Analysis (N AW7, formerly N AW7) (1) Prepare 
and analyze data on NIH sponsored biomedical research to inform trans-
NIH planning and coordination; (2) serve as a resource for portfolio 
management at the programmatic level; (3) employ databases, analytic 
tools, methodologies and other resources to conduct assessments in 
support of portfolio analyses and priority setting in scientific areas 
of interest across NIH; (4) research and develop new analytic tools, 
support systems, and specifications for new resources in coordination 
with other NIH organizations to enhance the management of the NIH's 
scientific portfolio; and (5) provide, in coordination with other NIH 
organizations, training on portfolio analysis tools, procedures, and 
methodology.
    Office of Program Evaluation and Performance (N AW8, formerly N 
AW8) (1) Plan, conduct, coordinate, and support program evaluations, 
including IC-specific program and project evaluations and trans-NIH 
evaluations; (2) manage and administer NIH's Evaluation Set-Aside 
Program; (3) coordinate and direct the preparation of plans and reports 
required by the Government Performance and Results Act (GPRA), 
including the development of required performance measures; (4) 
identify and advise on emerging national issues within program 
evaluation and performance, including NIH's response to legislative, 
regulatory, and policy requirements of the GPRA and administration of 
the NIH-wide evaluation program.
    Delegations of Authority Statement: All delegations and 
redelegations of authority to officers and employees of NIH that were 
in effect immediately prior to the effective date of this 
reorganization and are consistent with this reorganization shall 
continue in effect, pending further redelegation.

    Dated: January 21, 2011.
LaVerene Stringfield,
Associate Director for Management, OD, ES, NIH.
[FR Doc. 2011-2848 Filed 2-8-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.